(Post-pandemic Era) - Global Oncology Biosimilars Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021

(Post-pandemic Era) - Global Oncology Biosimilars Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021

Table of Contents

Global Oncology Biosimilars Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 G-CSF -Product Introduction and Major Manufacturers
1.1.2 Hematopoietic Agents -Product Introduction and Major Manufacturers
1.1.3 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2020-2027)
2.2 Regional Market Share in Terms of Revenue (2020-2027)
2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Oncology Biosimilars Market Assessment by Type
3.1 Global Oncology Biosimilars Production by Type (2016-2027)
3.2 Global Oncology Biosimilars Revenue by Type (2016-2027)
3.3 North America Oncology Biosimilars Production and Revenue by Type (2016-2027)
3.4 Asia Oncology Biosimilars Production and Revenue by Type (2016-2027)
3.5 Europe Oncology Biosimilars Production and Revenue by Type (2016-2027)
3.6 Middle East & Africa Oncology Biosimilars Production and Revenue by Type (2016-2027)
3.7 South America Oncology Biosimilars Production and Revenue by Type (2016-2027)
4 Global Oncology Biosimilars Market Assessment by Application
4.1 Historical & Forecast Global Oncology Biosimilars Consumption, Different Application Field (2016-2027)
4.2 Historical & Forecast North America Oncology Biosimilars Consumption, Different Application Field (2016-2027)
4.3 Historical & Forecast Asia Oncology Biosimilars Consumption, Different Application Field (2016-2027)
4.4 Historical & Forecast Europe Oncology Biosimilars Consumption, Different Application Field (2016-2027)
4.5 Historical & Forecast Middle East & Africa Oncology Biosimilars Consumption, Different Application Field (2016-2027)
4.6 Historical & Forecast South America Oncology Biosimilars Consumption, Different Application Field (2016-2027)
5 North America
5.1 US Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.2 Canada Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.3 Mexico Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
6.1 China Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.2 Japan Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.3 India Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.4 Korea Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.5 Southeat Asia Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
7.1 Germany Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.2 UK Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.3 France Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.4 Russia Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.5 Italy Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
8.1 Saudi Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.2 UAE Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.3 Egypt Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.4 Nigeria Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.5 South Africa Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
9.1 Brazil Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.2 Argentina Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.3 Colombia Oncology Biosimilars Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Oncology Biosimilars Average Price Trend
10.1 Market Price for Each Type of Oncology Biosimilars in North America (2016-2027)
10.2 Market Price for Each Type of Oncology Biosimilars in Asia (2016-2027)
10.3 Market Price for Each Type of Oncology Biosimilars in Europe (2016-2027)
10.4 Market Price for Each Type of Oncology Biosimilars in Middle East & Africa (2016-2027)
10.5 Market Price for Each Type of Oncology Biosimilars in South America (2016-2027)
11 Value Chain (Impact of COVID-19)
11.1 Oncology Biosimilars Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Oncology Biosimilars Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Oncology Biosimilars Competitive Analysis
12.1 Celltrion Inc.
12.1.1 Celltrion Inc. Company Profiles
12.1.2 Celltrion Inc. Product Introduction
12.1.3 Celltrion Inc. Oncology Biosimilars Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Pfizer Inc.
12.2.1 Pfizer Inc. Company Profiles
12.2.2 Pfizer Inc. Product Introduction
12.2.3 Pfizer Inc. Oncology Biosimilars Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Biocon
12.3.1 Biocon Company Profiles
12.3.2 Biocon Product Introduction
12.3.3 Biocon Oncology Biosimilars Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 BIOCAD
12.4.1 BIOCAD Company Profiles
12.4.2 BIOCAD Product Introduction
12.4.3 BIOCAD Oncology Biosimilars Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 STADA Arzneimittel AG
12.5.1 Apotex Inc. Company Profiles
12.5.2 Apotex Inc. Product Introduction
12.5.3 Apotex Inc. Oncology Biosimilars Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 Dr. Reddy's Laboratories Ltd.
12.6.1 Dr. Reddy's Laboratories Ltd. Company Profiles
12.6.2 Dr. Reddy's Laboratories Ltd. Product Introduction
12.6.3 Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Sandoz International GmbH
12.7.1 Sandoz International GmbH Company Profiles
12.7.2 Sandoz International GmbH Product Introduction
12.7.3 Sandoz International GmbH Oncology Biosimilars Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Intas Pharmaceuticals Ltd.
12.8.1 Intas Pharmaceuticals Ltd. Company Profiles
12.8.2 Intas Pharmaceuticals Ltd. Product Introduction
12.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 STADA Arzneimittel AG
12.9.1 STADA Arzneimittel AG Company Profiles
12.9.2 STADA Arzneimittel AG Product Introduction
12.9.3 STADA Arzneimittel AG Oncology Biosimilars Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Company Profiles
12.10.2 Teva Pharmaceutical Industries Ltd. Product Introduction
12.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
13 Conclusion

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
Figure Global Oncology Biosimilars Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2016-2027)
Table Regional Market Share in Terms of Production (2020-2027)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2020-2027)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure Global Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Production Market Share (%) by Type (2019 -2020)
Table Global Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Revenue Market Share (%) by Type (2019-2020)
Figure North America Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure North America Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure North America Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Figure Asia Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure Asia Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure Asia Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Figure Europe Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure Europe Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure Europe Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Figure Middle East & Africa Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure Middle East & Africa Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure Middle East & Africa Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure Middle East & Africa Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Figure South America Oncology Biosimilars Production (K Unit) by Type (2016-2027)
Figure South America Oncology Biosimilars Production (K Unit) and Growth Rate (2016-2027)
Figure South America Oncology Biosimilars Revenue (Million USD) by Type (2016-2027)
Figure South America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2016-2027)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure North America Oncology Biosimilars Consumption (K Unit) and Growth Rate (2016-2027)
Figure North America Oncology Biosimilars Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure Asia Oncology Biosimilars Consumption (K Unit) and Growth Rate (2016-2027)
Figure Asia Oncology Biosimilars Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure Europe Oncology Biosimilars Consumption (K Unit) and Growth Rate (2016-2027)
Figure Europe Oncology Biosimilars Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure Middle East & Africa Oncology Biosimilars Consumption (K Unit) and Growth Rate (2016-2027)
Figure Middle East & Africa Oncology Biosimilars Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Figure South America Oncology Biosimilars Consumption (K Unit) and Growth Rate (2016-2027)
Figure South America Oncology Biosimilars Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Oncology Biosimilars Different Application Field Consumption (K Unit)
Table US Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Oncology Biosimilars Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in China
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in EU
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in USA
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in Japan
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in India
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Oncology Biosimilars in South America
Figure Value Chain Structure of Oncology Biosimilars
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Oncology Biosimilars
Figure Cost Structure of Oncology Biosimilars in 2020
Table Distributors/Traders List
Table Celltrion Inc. Profiles
Table Celltrion Inc. Oncology Biosimilars Product Introduction
Figure Celltrion Inc. Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Celltrion Inc. SWOT Analysis
Table Pfizer Inc. Profiles
Table Pfizer Inc. Oncology Biosimilars Product Introduction
Figure Pfizer Inc. Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Pfizer Inc. SWOT Analysis
Table Biocon Profiles
Table Biocon Oncology Biosimilars Product Introduction
Figure Biocon Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Biocon SWOT Analysis
Table BIOCAD Profiles
Table BIOCAD Oncology Biosimilars Product Introduction
Figure BIOCAD Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure BIOCAD SWOT Analysis
Table Apotex Inc. Profiles
Table Apotex Inc. Oncology Biosimilars Product Introduction
Figure Apotex Inc. Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Apotex Inc. SWOT Analysis
Table Dr. Reddy's Laboratories Ltd. Profiles
Table Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Product Introduction
Figure Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Dr. Reddy's Laboratories Ltd. SWOT Analysis
Table Sandoz International GmbH Profiles
Table Sandoz International GmbH Oncology Biosimilars Product Introduction
Figure Sandoz International GmbH Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Sandoz International GmbH SWOT Analysis
Table Intas Pharmaceuticals Ltd. Profiles
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Product Introduction
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Intas Pharmaceuticals Ltd. SWOT Analysis
Table STADA Arzneimittel AG Profiles
Table STADA Arzneimittel AG Oncology Biosimilars Product Introduction
Figure STADA Arzneimittel AG Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure STADA Arzneimittel AG SWOT Analysis
Table Teva Pharmaceutical Industries Ltd. Profiles
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Product Introduction
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs